New NICE Guidelines – identification and management of adrenal insufficiency
The publication of new NICE (National Institute for Health and Care Excellence) guidelines – “Adrenal insufficiency: identification and management” marks a significant advancement in the management and treatment of primary, secondary and tertiary adrenal insufficiency.
These guidelines provide updated, evidence-based recommendations designed to improve diagnosis, treatment, and long-term care for individuals with adrenal insufficiency.
By setting clear standards, the new guidelines aim to enhance patient outcomes, ensure timely interventions, and reduce assoicated risks – including that of adrenal crisis.
Read the guidelines on the NICE website here.
Recent Blog Posts
Article: Adult Quality of Life with CAH
A new study published in Endocrine Connections explores the lived experiences of adults with congenital adrenal hyperplasia (CAH) and the wide-ranging impact the condition can have on quality of life. Through in-depth interviews with adults living with CAH as well as...
Liquid Hydrocortisone Discontinued in the UK
Liquid hydrocortisone injections have been discontinued in the UK, affecting emergency treatment for people with adrenal insufficiency. This follows the supply shortage reported in February 2025 -...
Medicine security – a national UK priority.
Concerns about medicines shortages in the UK have been highlighted in recent analysis from the House of Lords Public Services Committee and the Royal Pharmaceutical Society. The House of Lords Public Services Committee warns that medicines supply should be treated as...